SUNDAY, Aug. 10, 2014 (HealthDay News) -- Many pregnant women
and their unborn children are being exposed to antibacterial
compounds that may be linked to developmental and reproductive
issues, a new small study suggests.
The antibacterial triclosan appeared in the urine of every woman
tested in the study, and triclocarban, another antibacterial
chemical, appeared in more than 85 percent of the urine samples,
the researchers report.
Potentially worse, triclosan also showed up in more than half
the samples of umbilical cord blood taken from the mothers,
indicating that the chemical is reaching some fetuses.
The U.S. Food and Drug Administration is reviewing the safety of
triclosan following animal studies that showed the chemical can
affect the way hormones function.
Such interference -- known as endocrine disruption -- can
potentially affect the development of an unborn fetus, said study
co-author Laura Geer, an assistant professor of environmental and
occupational health sciences at SUNY Downstate School of Public
"These compounds have endocrine-disrupting potential, and the fetus is particularly vulnerable during its development to hormonal changes," Geer said.
Triclosan and triclocarban are used in more than 2,000 everyday
consumer products, including toothpastes, soaps, detergents,
carpets, paints, school supplies and toys, the researchers
Prominent manufacturers such as Avon, Proctor & Gamble and
Johnson & Johnson have announced that they are phasing out
triclosan from their products. Minnesota has become the first state
to pass a ban on the antimicrobial's use in certain products, which
will take effect in January 2017.
In this study, researchers took urine and cord blood samples
from 184 pregnant women in Brooklyn, N.Y.
They found levels of triclosan and triclocarban in nearly all
the women tested.
Researchers also found another antibacterial agent, butyl
paraben, in a majority of urine and cord blood samples.
The results revealed a link between butyl paraben, which is
commonly used in cosmetics, and shorter lengths of newborns, Geer
said. If the finding is confirmed in larger studies, it could mean
that widespread exposure to these compounds might cause a subtle,
but large-scale, shift in birth sizes.
The findings were presented Sunday at the American Chemical
Society annual meeting in San Francisco. Research presented at
meetings is considered preliminary until published in a
peer-reviewed medical journal.
An industry group, the Personal Care Council, did not respond to
a request for comment.
All three antibacterial agents are of dubious benefit and could
be easily eliminated from products, said Andrea Gore, a spokeswoman
for The Endocrine Society and a professor of pharmacology and
toxicology at the University of Texas at Austin.
"The efficacy of these products as being helpful to human health has not been proven, but companies are adding them to products anyway," Gore said. "There's no downside to removing chemicals that have no proven benefit."
The potential impact of these chemicals on unborn children is
particularly troubling, Gore said.
"During early development, very small amounts of hormone have very big effects on developmental processes," she said. "We know that development is such a vulnerable period for exposure to natural hormones. We know that hormones in the fetus and in the infant are really important for neurobiological development."
U.S. Food and Drug Administrationfor more on
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.